GNRH AGONIST VERSUS HCG TO INDUCE FINAL OOCYTE MATURATION IN PATIENTS AT LOW RISK OF OHSS

被引：0
|
作者：
Green, K. A. [1 ]
Healy, M. W. [1 ,2 ]
DeCherney, A. H. [1 ]
Beall, A. S. [3 ]
Chang, F. E. [3 ]
Devine, K. [3 ]
Hill, M. J. [1 ,2 ]
机构：
[1] NICHHD, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA
[2] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA
[3] Shady Grove Fertil, Rockville, MD USA
来源：
FERTILITY AND STERILITY | 2018年 / 109卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2018.02.055
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-25
引用
收藏
页码：E28 / E28
页数：1
相关论文
共 50 条
  • [11] Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation
    Kol, Shahar
    Dor, Jehoshua
    REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (01) : 59 - 60
  • [12] Triggering final oocyte maturation with a GnRH agonist in egg donors does not reduce implantation and pregnancy rates and eliminates the risk of OHSS
    Pena, V.
    Chinea, E.
    Sanabria, V.
    Hernandez, J.
    Palumbo, A.
    HUMAN REPRODUCTION, 2007, 22 : I123 - I123
  • [13] hCG Salvage after Failed GnRH Agonist Trigger for Final Oocyte Maturation in IVF Cycles
    Moon, Kimberly S.
    Levens, Eric D.
    Richter, Kevin S.
    DeCherney, Alan H.
    Chang, Frank E.
    REPRODUCTIVE SCIENCES, 2011, 18 (03) : 117A - 117A
  • [14] Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes
    Zilberberg, Eran
    Haas, Jigal
    Dar, Shir
    Kedem, Alon
    Machtinger, Ronit
    Orvieto, Raoul
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (02) : 145 - 147
  • [15] Cumulative live birth rates after GnRH-agonist triggering of final oocyte maturation in patients at risk of OHSS: A prospective, clinical cohort study
    Griesinger, Georg
    Berndt, Henriette
    Schultz, Laura
    Depenbusch, Marion
    Schultze-Mosgau, Askan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 149 (02) : 190 - 194
  • [16] GnRH agonist for triggering final oocyte maturation in patients with PCO at high risk for severe OHSS: factors predicting live birth in subsequent FRET cycles
    Tarlatzi, T.
    Bosdou, J.
    Venetis, C.
    Lainas, G.
    Sfontouris, I.
    Makedos, A.
    Chatzimeletiou, K.
    Zepiridis, L.
    Mitsoli, A.
    Savaidou, D.
    Lainas, T.
    Tarlatzis, B.
    Kolibianakis, E.
    HUMAN REPRODUCTION, 2016, 31 : 129 - 130
  • [17] Cumulative pregnancy rates when using GNRH agonist instead of HCG for final oocyte maturation.
    Daneshmand, S. T.
    Shapiro, B. S.
    Garner, F. C.
    Aguirre, M.
    Ross, R.
    FERTILITY AND STERILITY, 2006, 86 : S184 - S185
  • [18] CO-ADMINISTRATION OF GNRH-AGONIST AND HCG, FOR FINAL OOCYTE MATURATION (DOUBLE TRIGGER), IN PATIENTS WITH LOW RATE OF MATURE OOCYTES.
    Zilberberg, E.
    Haas, J.
    Dar, S.
    Kedem, A.
    Machtinger, R.
    Orvieto, R.
    FERTILITY AND STERILITY, 2014, 102 (03) : E22 - E23
  • [19] GNRH antagonist administration to decrease risk of OHSS in GNRH agonist cycles triggered with HCG
    Mills, G.
    Dahan, S. Y.
    Dahan, M. H.
    HUMAN REPRODUCTION, 2020, 35 : 108 - 108
  • [20] GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?
    Kol, S.
    Solt, I.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2008, 25 (2-3) : 63 - 66
12345